Descazeaux, Mathilde
Brouquières, Danièle
Didier, Alain
Lescouzères, Marianne
Napoléon, Marie-Françoise
Escamilla, Roger
Guilleminault, Laurent http://orcid.org/0000-0002-7344-8290
Article History
Received: 26 December 2019
Accepted: 24 April 2020
First Online: 30 April 2020
Compliance with Ethical Standards
:
: Mathilde Descazeaux and Marianne Lescouzères have no conflict of interests. Danièle Brouquières has participated in clinical trials sponsored by Astra Zeneca, MSD, ZAMBON and NOVARTIS. Alain Didier has received consultation fees from ALK, Astrazenenca, Chiesi, GlaxoSmithKline, Novartis Boerhinger Ingelheim, Menarini, and Zambon. Marie-Françoise Napoléon has received non-financial support by Alphasigma and has participated in clinical trials sponsored by Mayoli Spindler. Roger Escamilla has received consultation fees from MSD, Novartis and Boerhinger Ingelheim. Laurent Guilleminault has received consultation fees from ALK, Astrazenenca, Bayer, Chiesi, GlaxoSmithKline, Novartis and Boerhinger Ingelheim and non-financial support from ALK, Astrazenenca, Boerhinger Ingelheim, Novartis and Pierre Fabre. Laurent Guilleminault has received grants from Axdom Réunion, ISIS Réunion, Resmed and Seprodom.